Drug Profile
Tazarotene topical - Dr Reddys Laboratories
Alternative Names: DFD-03Latest Information Update: 27 Oct 2020
Price :
$50
*
At a glance
- Originator Dr Reddys Laboratories
- Class Antiacnes; Antipsoriatics; Esters; Keratolytics; Nicotinic acids; Pyrans; Pyridines; Retinoids; Small molecules
- Mechanism of Action Retinoid X receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Acne vulgaris
Most Recent Events
- 15 Jun 2020 No development reported - Phase-II for Acne vulgaris in Germany (Topical)
- 15 Jun 2020 Regulatory submission withdrawn for Acne vulgaris (In adolescents, In children, In the elderly, In adults) in USA (Topical) before June 2020
- 14 Jun 2020 Preregistration for Acne vulgaris (In adolescents, In children, In the elderly, In adults) in USA (Topical) before June 2020